Analyst PT Change
This category tracks notable price target changes from analysts on Wall Street. For a summary of today's ratings movers please visit Ratings Insider.
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) PT Lowered to $33 at RBC Capital
-
-
-
-
-
-
-
American Public Education (APEI) PT Raised to $31 at B.Riley
-
-
-
-
-
-
-
Getty Realty (GTY) PT Lowered to $29 at UBS
-
-
-
-
-
-
-
CAVA Group Inc (CAVA) PT Lowered to $112 at UBS
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Lowered to $40 at RBC Capital
-
-
-
-
-
-
-
Hub Group (HUBG) PT Raised to $40 at Benchmark
-
-
-
-
-
-
-
Repay (RPAY) PT Lowered to $5 at BMO Capital Following 'Conclusion of Strategic Review'
-
619,963 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst PT Change reports.